Lung cancer susceptibility and genetic polymorphisms of Exo1 gene in Taiwan

Anticancer Research

Volumn 29, Issue 2, 2009, Pages 725-730

  Hsu, N Y ^a   Wang, Hwei Chung ^a   Wang, Chung Hsing ^a   Chiu, Chang Fang ^a   Tseng, Hsien Chang ^a   Liang, Shiu Yun ^a   Tsai, Chia Wen ^a,b   Lin, Cheng Chieh ^a,c   Bau, Da Tian ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

Author keywords

Carcinogenesis; Exo1; Lung cancer; Polymorphism

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; EXO1 GENE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; TAIWAN;

ALKADIENES; CASE-CONTROL STUDIES; DNA REPAIR ENZYMES; EXODEOXYRIBONUCLEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; TAIWAN;

EID: 61449228549     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Chiu HF, Cheng MH, Tsai SS, Wu TN, Kuo HW and Yang CY: Outdoor air pollution and female lung cancer in Taiwan. Inhal Toxicol 18: 1025-1031, 2006.
3. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics. CA Cancer J Clin 57: 43-66, 2007.
4. Yang L, Parkin DM, Li L and Chen Y: Time trends in cancer mortality in China: 1987-1999. Int J Cancer 106: 771-783, 2003.
5. Yang L, Parkin DM, Ferlay J, Li L and Chen Y: Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14: 243-250, 2005.
6. Zhang H and Cai B: The impact of tobacco on lung health in China. Respirology 5: 17-21, 2003.
7. Hecht SS: Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer 3: 733-744, 2003.
8. Iyer RR, Pluciennik A, Burdett V and Modrich PL: DNA mismatch repair: functions and mechanisms. Chem Rev 106: 302-323, 2006.
9. Li GM: DNA mismatch repair and cancer. Front Biosci 8: 997-1017, 2003.
10. Xinarianos G, Liloglou T and PrimeW: hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas. Cancer Res 60: 4216-4221, 2000.
11. Wang YC, Lu YP and Tseng RC: Inactivation of hMLH1 and hMSH2 by promoter methylation in primary non-small cell lung tumors and matched sputum samples. J Clin Invest 111: 887-895, 2003.
12. Wilson III DM, Carney JP, Coleman MA, Adamson AW, Christensen M and Lamerdin JE: Hex1: a new human Rad2 nuclease family member with homology to yeast exonuclease 1. Nucleic Acids Res 26: 3762-3768, 1998.
13. Tishkoff DX, Amin NS, Viars CS, Arden KC and Kolodner RD: Identification of a human gene encoding a homologue of Saccharomyces cerevisiae EXO1, an exonuclease implicated in mismatch repair and recombination. Cancer Res 58: 5027-5031, 1998.
14. Schmutte C, Marinescu RC, Sadoff MM, Guerrette S, Overhauser J and Fishel R: Human exonuclease I interacts with the mismatch repair protein hMSH2. Cancer Res 58: 4537-4542, 1998.
15. Tishkoff DX, Boerger AL and Bertrand P: Identification and characterization of Saccharomyces cerevisiae EXO1, a gene encoding an exonuclease that interacts with MSH2. Proc Natl Acad Sci USA 94: 7487-7492, 1997.
16. Rasmussen LJ, Rasmussen M and Lee BI: Identification of factors interacting with hMSH2 in the fetal liver utilizing the yeast two-hybrid system. In vivo interaction through the C-terminal domains of hEXO1 and hMSH2 and comparative expression analysis. Mutat Res 460: 41-52, 2000.
17. Jager AC, Rasmussen M, Bisgaard HC, Singh KK, Nielsen FC and Rasmussen LJ: HNPCC mutations in the human DNA mismatch repair gene hMLH1 influence assembly of hMutLa and hMLH1-hEXO1 complexes. Oncogene 20: 3590-3595, 2001.
18. Schmutte C, Sadoff MM, Shim KS, Acharya S and Fishel R: The interaction of DNA mismatch repair proteins with human exonuclease I. J Biol Chem 276: 33011-33018, 2001.
19. Tran PT, Simon JA and Liskay RM: Interactions of Exo1p with components of MutLa in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 98: 9760-9765, 2001.
20. Wei K, Clark AB and Wong E: Inactivation of Exonuclease 1 in mice results in DNA mismatch repair defects, increased cancer susceptibility, and male and female sterility. Genes Dev 17: 603-614, 2003.
21. Bau DT, Tseng HC and Wang CH: Oral cancer and genetic polymorphism of DNA double-strand break gene Ku70 in Taiwan. Oral Oncol 44: 1047-1051, 2008.
22. Chiu CF, Tsai MH and Tseng HC: A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol 44: 898-902, 2008.
23. Chiu CF, Tsai MH and Tseng HC: A novel single nucleotide polymorphism in the ERCC6 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral Oncol 44: 582-586, 2008.
24. Chiu CF, Wang CH and Wang CL: A novel single nucleotide polymorphism in the XRCC4 gene is associated with gastric cancer susceptibility in Taiwan. Ann Surg Oncol 15: 514-518, 2008.
25. Chiu CF, Wang HC and Wang CH: A new single nucleotide polymorphism in the XRCC4 gene is associated with breast cancer susceptibility in Taiwanese patients. Anticancer Res 28: 267-270, 2008.
26. Bau DT, Wu HC and Chiu CF: Association of XPD polymorphisms with prostate cancer in Taiwanese patients. Anticancer Res 27: 2893-2896, 2008.
27. Yamamoto H, Hanafusa H, Ouchida M, Yano M, Suzuki H and Murakami M: Single nucleotide polymorphisms in the EXO1 gene and risk of colorectal cancer in a Japanese population. Carcinogenesis 26: 411-416, 2005.
28. Jin G, Wang H and Hu Z: Potentially functional polymorphisms of EXO1 and risk of lung cancer in a Chinese population: A case-control analysis. Lung Cancer 60: 340-346, 2008.
29. Marti TM, Kunz C and Fleck O: DNA mismatch repair and mutation avoidance pathways. J Cell Physiol 191: 28-41, 2002.
30. Modrich P and Lahue R: Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu Rev Biochem 65: 101-133, 1996.
31. Liberti SE and Rasmussen LJ: Is hEXO1 a cancer predisposing gene? Mol Cancer Res 2: 427-432, 2004.
32. Wu Y, Berends MJ and Post JG: Germline mutations of EXO1 gene in patients with hereditary nonpolyposis colorectal cancer (HNPCC) and atypical HNPCC forms. Gastroenterology 120: 1580-1587, 2001.
33. Jagmohan-Changur S, Poikonen T and Vilkki S: EXO1 variants occur commonly in the normal population: evidence against a role in hereditary nonpolyposis colorectal cancer. Cancer Res 63: 154-158, 2003.
34. Thompson E, Meldrum CJ and Crooks R: Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations. Clin Genet 65: 215-225, 2004.
35. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, Phillips DH, Canzian F, Haugen A. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 27(3): 560-567, 2006.